BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30343119)

  • 1. Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB/c mice.
    Golshani M; Amani M; Siadat SD; Nejati-Moheimani M; Arsang A; Bouzari S
    Mol Immunol; 2018 Nov; 103():306-311. PubMed ID: 30343119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
    Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using Omp2b in BALB/c Mice.
    Golshani M; Rafati S; Nejati-Moheimani M; Ghasemian M; Bouzari S
    Vet Microbiol; 2016 Dec; 197():47-52. PubMed ID: 27938682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S; Singh D; Gupta M; Bhatnagar R
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein/Protein, DNA/DNA and DNA/Protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB/c Mice.
    Golshani M; Rafati S; Nejati-Moheimani M; Pourabdi S; Arsang A; Bouzari S
    Int J Med Microbiol; 2017 Jun; 307(4-5):249-256. PubMed ID: 28391992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Poly(I:C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice.
    Golshani M; Amani M; Amirzadeh F; Nazeri E; Davar Siadat S; Nejati-Moheimani M; Arsang A; Bouzari S
    Int Immunopharmacol; 2020 Jul; 84():106573. PubMed ID: 32454410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial Protective Immunity Conferred by a Combination of
    Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
    J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brucella antigens (BhuA, 7α-HSDH, FliC) in poly I:C adjuvant as potential vaccine candidates against brucellosis.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    J Immunol Methods; 2022 Jan; 500():113172. PubMed ID: 34673003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Yespembetov B; Zinina N; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Gotskina T; Sansyzbay A
    Vaccine; 2014 Apr; 32(18):2034-41. PubMed ID: 24598723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A; Mahmoud NH; Hammoud R
    Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Different aluminum adjuvants significantly enhances the effect of immunization on Brucella Omp31].
    Qing R; Xiang Q; Liu Z; Xiao F; Yang F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):123-128. PubMed ID: 29673454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection.
    Oliveira SC; Splitter GA
    Vaccine; 1996 Jul; 14(10):959-62. PubMed ID: 8873388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
    Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
    Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.